γ-사이클로덱스트린

γ-사이클로덱스트린
γ-사이클로덱스트린 구조식 이미지
카스 번호:
17465-86-0
한글명:
γ-사이클로덱스트린
동의어(한글):
γ-사이클로덱스트린
상품명:
gamma-Cyclodextrin
동의어(영문):
GAMMA-CYCLODEXTRIN;Resistant Dextrin;gammadex;CYCLOMALTOOCTAOSE;GCD;γ-CycL;gamma-CD;Ringdex C;schardinger;Cavasol? W8
CBNumber:
CB9750405
분자식:
C48H80O40
포뮬러 무게:
1297.12
MOL 파일:
17465-86-0.mol
MSDS 파일:
SDS

γ-사이클로덱스트린 속성

녹는점
≥300 °C
끓는 점
845.2°C (rough estimate)
알파
[α]D25 +174~+179° (c=1, H2O) (After Drying)
밀도
1.2064 (rough estimate)
굴절률
1.7500 (estimate)
인화점
450℃
저장 조건
room temp
용해도
1M NaOH: 25mg/mL, 투명하거나 약간 흐릿할 수 있음
물리적 상태
가루
산도 계수 (pKa)
11.68±0.70(Predicted)
색상
하얀색
냄새
100.00%. 냄새 없는
optical activity
[α]/D 174.0 to 180.0°
수용성
232g/L(25℃)
최대 파장(λmax)
λ: 420 nm Amax: ≤0.20
Merck
14,2718
BRN
5725162
안정성
흡습성
InChIKey
GDSRMADSINPKSL-HSEONFRVSA-N
LogP
-12.02
EPA
.gamma.-Cyclodextrin (17465-86-0)
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
위험품 표기 Xi
위험 카페고리 넘버 36/37/38
안전지침서 26-36-24/25-22
WGK 독일 2
RTECS 번호 GU2293080
F 고인화성물질 3
HS 번호 29400000
기존화학 물질 2013-3-5585
그림문자(GHS): GHS hazard pictograms
신호 어: Warning
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H315 피부에 자극을 일으킴 피부부식성 또는 자극성물질 구분 2 경고 GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 눈에 심한 자극을 일으킴 심한 눈 손상 또는 자극성 물질 구분 2A 경고 GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
예방조치문구:
P280 보호장갑/보호의/보안경/안면보호구를 착용하시오.
P302+P352 피부에 묻으면 다량의 물로 씻으시오.
P305+P351+P338 눈에 묻으면 몇 분간 물로 조심해서 씻으시오. 가능하면 콘택트렌즈를 제거하시오. 계속 씻으시오.
P332+P313 피부 자극이 생기면 의학적인 조치· 조언을 구하시오.
P337+P313 눈에 대한 자극이 지속되면 의학적인 조치· 조언를 구하시오.

γ-사이클로덱스트린 MSDS


gamma-Cyclodextrin

γ-사이클로덱스트린 C화학적 특성, 용도, 생산

화학적 성질

White powder or crystal

용도

A molecule used to solublize non-polar molecules such a cholesterol for use in cell culture.

생산 방법

Cyclodextrins are manufactured by the enzymatic degradation of starch using specialized bacteria. For example, β-cyclodextrin is produced by the action of the enzyme cyclodextrin glucosyltransferase upon starch or a starch hydrolysate. An organic solvent is used to direct the reaction that produces β-cyclodextrin, and to prevent the growth of microorganisms during the enzymatic reaction. The insoluble complex of β-cyclodextrin and organic solvent is separated from the noncyclic starch, and the organic solvent is removed in vacuo so that less than 1 ppm of solvent remains in the β-cyclodextrin. The β-cyclodextrin is then carbon treated and crystallized from water, dried, and collected.

일반 설명

Cyclodextrins belongs to the family of cyclic α-1,4-glucans and is made of glucose units. This molecule has a shape of a hollow cone. It possesses a hydrophilic external and hydrophobic internal surface, because of which cyclodextrins can form inclusion complexes. γ-Cyclodextrin is extensively used in food and pharmaceutical industries. Cyclodextrins are obtained by the enzymatic conversion of starch/starch derivatives by cyclodextrin glycosyltransferase.

Pharmaceutical Applications

Cyclodextrins are ‘bucketlike’ or ‘conelike’ toroid molecules, with a rigid structure and a central cavity, the size of which varies according to the cyclodextrin type. The internal surface of the cavity is hydrophobic and the outside of the torus is hydrophilic; this is due to the arrangement of hydroxyl groups within the molecule. This arrangement permits the cyclodextrin to accommodate a guest molecule within the cavity, forming an inclusion complex.
Cyclodextrins may be used to form inclusion complexes with a variety of drug molecules, resulting primarily in improvements to dissolution and bioavailability owing to enhanced solubility and improved chemical and physical stability.
Cyclodextrin inclusion complexes have also been used to mask the unpleasant taste of active materials and to convert a liquid substance into a solid material. γ-cyclodextrin has the largest cavity and can be used to form inclusion complexes with large molecules;it has low toxicity and enhanced water solubility.
In parenteral formulations, cyclodextrins have been used to produce stable and soluble preparations of drugs that would otherwise have been formulated using a nonaqueous solvent.
In eye drop formulations, cyclodextrins form water-soluble complexes with lipophilic drugs such as corticosteroids. They have been shown to increase the water solubility of the drug; to enhance drug absorption into the eye; to improve aqueous stability; and to reduce local irritation.
Cyclodextrins have also been used in the formulation of solutions,suppositories, and cosmetics.

Safety

Cyclodextrins are starch derivatives and are mainly used in oral and parenteral pharmaceutical formulations. They are also used in topical and ophthalmic formulations.
Cyclodextrins are also used in cosmetics and food products, and are generally regarded as essentially nontoxic and nonirritant materials. However, when administered parenterally, β-cyclodextrin is not metabolized but accumulates in the kidneys as insoluble cholesterol complexes, resulting in severe nephrotoxicity.
Cyclodextrin administered orally is metabolized by microflora in the colon, forming the metabolites maltodextrin, maltose, and glucose; these are themselves further metabolized before being finally excreted as carbon dioxide and water. Although a study published in 1957 suggested that orally administered cyclodextrins were highly toxic, more recent animal toxicity studies in rats and dogs have shown this not to be the case, and cyclodextrins are now approved for use in food products and orally administered pharmaceuticals in a number of countries.
Cyclodextrins are not irritant to the skin and eyes, or upon inhalation. There is also no evidence to suggest that cyclodextrins are mutagenic or teratogenic.
γ-Cyclodextrin
LD50 (rat, IP): 4.6 g/kg
LD50 (rat ,IV): 4.0 g/kg
LD50 (rat, oral): 8.0 g/kg

저장

Cyclodextrins should be stored in a tightly sealed container, in a cool, dry place.Cyclodextrins are stable in the solid state if protected from high humidity.

Regulatory Status

Included in the FDA Inactive Ingredients Database: α-cyclodextrin (injection preparations); β-cyclodextrin (oral tablets, topical gels); γ-cyclodextrin (IV injections).
Included in the Canadian List of Acceptable Non-medicinal Ingredients (stabilizing agent; solubilizing agent ); and in oral and rectal pharmaceutical formulations licensed in Europe, Japan, and the USA.

γ-사이클로덱스트린 준비 용품 및 원자재

원자재

준비 용품


γ-사이클로덱스트린 공급 업체

글로벌( 427)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Henan Allgreen Chemical Co.,LTD
+86-37155567971 +86-13633837469
info@allgreenchem.com China 5986 58
Wuhan Fortuna Chemical Co., Ltd
+86-27-59207850 +86-13986145403
info@fortunachem.com China 5988 58
Hebei Mojin Biotechnology Co., Ltd
+8613288715578
sales@hbmojin.com China 12456 58
Hebei Yanxi Chemical Co., Ltd.
+8617531190177
peter@yan-xi.com China 5993 58
Henan Fengda Chemical Co., Ltd
+86-371-86557731 +86-13613820652
info@fdachem.com China 7845 58
Shandong Juchuang Chemical Co., LTD
+86-18885615001 +86-18885615001
admin@juchuangchem.com China 387 58
airuikechemical co., ltd.
+undefined86-15315557071
sales02@airuikechemical.com China 994 58
Hebei Saisier Technology Co., LTD
+86-18400010335 +86-13102810335
admin@hbsaisier.cn China 747 58
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806
sales@capotchem.com China 29797 60
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21691 55

γ-사이클로덱스트린 관련 검색:

Copyright 2019 © ChemicalBook. All rights reserved